(Q30990645)

English

Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 June 2017

Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey (English)

1 reference

Europe PubMed Central

28 June 2017

author name string

Hare W

1

1 reference

Europe PubMed Central

28 June 2017

WoldeMussie E

2

1 reference

Europe PubMed Central

28 June 2017

Lai R

3

1 reference

Europe PubMed Central

28 June 2017

Ton H

4

1 reference

Europe PubMed Central

28 June 2017

Ruiz G

5

1 reference

Europe PubMed Central

28 June 2017

Feldmann B

6

1 reference

Europe PubMed Central

28 June 2017

Wijono M

7

1 reference

Europe PubMed Central

28 June 2017

Chun T

8

1 reference

Europe PubMed Central

28 June 2017

Wheeler L

9

1 reference

Europe PubMed Central

28 June 2017

publication date

1 May 2001

1 reference

Europe PubMed Central

28 June 2017

Survey of Ophthalmology

1 reference

Europe PubMed Central

28 June 2017

45 Suppl 3

1 reference

Europe PubMed Central

28 June 2017

S284-9; discussion S295-6

1 reference

Europe PubMed Central

28 June 2017

Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Memantine reduces alterations to the mammalian retina, in situ, induced by ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan).

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine).

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0039-6257(01)00200-4

1 reference

Europe PubMed Central

28 June 2017

1 reference

Europe PubMed Central

28 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30990645&oldid=1980251031"